|
JP2884452B2
(ja)
|
1991-10-09 |
1999-04-19 |
清水建設株式会社 |
セグメントを利用した立坑構築工法
|
|
EP3219705B1
(en)
|
2005-12-28 |
2020-03-11 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions of the amorphous form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
|
EP3613743B1
(en)
|
2008-01-04 |
2022-03-16 |
Intellikine, LLC |
Processes for the preparation of 1h-pyrazolo[3,4-d]pyrimidin-4-amine derivatives
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
CA2739416C
(en)
|
2008-09-03 |
2017-10-31 |
Arbor Vita Corporation |
Agents and methods for treatment of pain
|
|
EP2521724B1
(en)
*
|
2009-12-11 |
2016-11-23 |
Nono Inc. |
Agents and methods for treating ischemic and other diseases
|
|
CA2799579A1
(en)
|
2010-05-21 |
2011-11-24 |
Intellikine, Inc. |
Chemical compounds, compositions and methods for kinase modulation
|
|
AU2011202542A1
(en)
*
|
2010-07-14 |
2012-02-02 |
Indian Institute Of Science |
Benzothiophene carboxamide compounds, composition and applications thereof
|
|
BR112013001138A2
(pt)
|
2010-07-16 |
2016-07-05 |
Abbvie Inc |
ligantes de fosfina para reações catalíticas
|
|
US8895737B2
(en)
|
2010-07-16 |
2014-11-25 |
Shashank Shekhar |
Process for preparing antiviral compounds
|
|
US9255074B2
(en)
|
2010-07-16 |
2016-02-09 |
Abbvie Inc. |
Process for preparing antiviral compounds
|
|
US8975443B2
(en)
|
2010-07-16 |
2015-03-10 |
Abbvie Inc. |
Phosphine ligands for catalytic reactions
|
|
DE202011110963U1
(de)
*
|
2010-11-05 |
2017-11-07 |
Senomyx, Inc. |
Verbindungen, die als Modulatoren von TRPM8 nützlich sind
|
|
WO2012071369A2
(en)
|
2010-11-24 |
2012-05-31 |
The Trustees Of Columbia University In The City Of New York |
A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease
|
|
TWI674262B
(zh)
|
2011-01-10 |
2019-10-11 |
美商英菲尼提製藥股份有限公司 |
製備異喹啉酮之方法及異喹啉酮之固體形式
|
|
US9334256B2
(en)
|
2011-06-15 |
2016-05-10 |
Nono Inc. |
Agents and methods for treating ischemic and other diseases
|
|
MX2014000648A
(es)
|
2011-07-19 |
2014-09-25 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos y sus usos.
|
|
KR20130016041A
(ko)
*
|
2011-08-04 |
2013-02-14 |
재단법인 의약바이오컨버젼스연구단 |
신규한 아닐린 유도체 및 이의 용도
|
|
KR20140075693A
(ko)
|
2011-08-29 |
2014-06-19 |
인피니티 파마슈티칼스, 인코포레이티드 |
헤테로사이클릭 화합물 및 그의 용도
|
|
US9539256B2
(en)
|
2012-02-10 |
2017-01-10 |
The Board Of Regents Of The University Of Texas System |
Modulators of exchange proteins directly activated by cAMP (EPACS)
|
|
US9051299B2
(en)
|
2012-03-29 |
2015-06-09 |
Merck Sharp & Dohme Corp. |
Imidazolyl methyl piperidine T-type calcium channel antagonists
|
|
WO2013166037A1
(en)
|
2012-05-01 |
2013-11-07 |
The Trustees Of Columbia University In The City Of New York |
Non-retinoid antagonists for treatment of eye disorders
|
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
|
CN103570705B
(zh)
*
|
2012-07-18 |
2017-01-25 |
中国医学科学院医药生物技术研究所 |
取代的n‑((1＇,3＇‑杂唑‑4＇‑基)‑甲基)‑4‑苯甲酰基六氢吡啶类化合物及其用途
|
|
BR112015004666B1
(pt)
|
2012-09-07 |
2022-04-26 |
Novartis Ag |
Derivados de indol carboxamida, seu uso, e composição farmacêutica
|
|
BR102012024778A2
(pt)
*
|
2012-09-28 |
2014-08-19 |
Cristalia Prod Quimicos Farm |
Compostos heteroaromáticos; processo para preparar os compostos, composições farmacêuticas, usos e método de tratamento para as dores aguda e crônica
|
|
EP2914296B2
(en)
|
2012-11-01 |
2021-09-29 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using pi3 kinase isoform modulators
|
|
EP2733146A1
(en)
*
|
2012-11-20 |
2014-05-21 |
KTB Tumorforschungsgesellschaft mbH |
Thioether derivatives as protein kinase inhibitors
|
|
WO2014079545A1
(en)
*
|
2012-11-20 |
2014-05-30 |
Ktb Tumorforschungsgesellschaft Mbh |
Thioether derivatives as protein kinase inhibitors
|
|
BR112015017768A2
(pt)
|
2013-01-25 |
2017-07-11 |
Glaxosmithkline Ip Dev Ltd |
compostos
|
|
TWI644899B
(zh)
|
2013-02-04 |
2018-12-21 |
健生藥品公司 |
Ｆｌａｐ調節劑
|
|
EP2951170B1
(en)
|
2013-02-04 |
2018-10-24 |
Janssen Pharmaceutica NV |
Flap modulators
|
|
US9938291B2
(en)
|
2013-03-14 |
2018-04-10 |
The Trustess Of Columbia University In The City Of New York |
N-alkyl-2-phenoxyethanamines, their preparation and use
|
|
US9944644B2
(en)
|
2013-03-14 |
2018-04-17 |
The Trustees Of Columbia University In The City Of New York |
Octahydropyrrolopyrroles their preparation and use
|
|
US9637450B2
(en)
|
2013-03-14 |
2017-05-02 |
The Trustees Of Columbia University In The City Of New York |
Octahydrocyclopentapyrroles, their preparation and use
|
|
EP2968304B1
(en)
|
2013-03-14 |
2018-10-10 |
The Trustees of Columbia University in the City of New York |
4-phenylpiperidines, their preparation and use
|
|
US9481667B2
(en)
|
2013-03-15 |
2016-11-01 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
|
WO2015039333A1
(en)
*
|
2013-09-22 |
2015-03-26 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
|
JP6498672B2
(ja)
*
|
2013-12-20 |
2019-04-10 |
エステベ ファーマシューティカルズ, ソシエダッド アノニマEsteve Pharmaceuticals, S.A. |
疼痛に対して多重モードの活性を有するピペリジン化合物
|
|
JP6940950B2
(ja)
|
2014-02-10 |
2021-09-29 |
アンスティテュ・キュリＩｎｓｔｉｔｕｔ Ｃｕｒｉｅ |
細胞遊走を調節するためのＭｃｏｌｎ−１モジュレータの使用
|
|
WO2015160975A2
(en)
|
2014-04-16 |
2015-10-22 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
EP4036094B1
(en)
|
2014-04-30 |
2025-12-24 |
The Trustees of Columbia University in the City of New York |
Substituted 4-phenylpiperidines, their preparation and use
|
|
WO2016049774A1
(en)
*
|
2014-10-03 |
2016-04-07 |
The Royal Institution For The Advancement Of Learning/Mcgill University |
Urea and bis-urea based compounds and analogues thereof useful in the treatment of androgen receptor mediated diseases or disorders
|
|
CN107250113B
(zh)
|
2014-10-07 |
2019-03-29 |
弗特克斯药品有限公司 |
囊性纤维化跨膜传导调节蛋白的调节剂的共晶
|
|
AU2015336480B2
(en)
|
2014-10-24 |
2020-04-02 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
WO2016077793A1
(en)
*
|
2014-11-14 |
2016-05-19 |
Children's Hospital Medical Center |
Sos1 inhibitors for cancer treatment
|
|
WO2016141092A1
(en)
|
2015-03-04 |
2016-09-09 |
Gilead Sciences, Inc. |
Toll-like receptor modulating 4,6-diamino-pyrido[3,2-d]pyrimidine compounds
|
|
US9737512B2
(en)
|
2015-03-11 |
2017-08-22 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions for treating chronic pain
|
|
LT3319959T
(lt)
|
2015-07-06 |
2021-12-27 |
Alkermes, Inc. |
Histono deacetilazės hetero-halogeno inhibitoriai
|
|
EP3319968A1
(en)
|
2015-07-06 |
2018-05-16 |
Rodin Therapeutics, Inc. |
Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
|
|
MX389514B
(es)
|
2015-10-01 |
2025-03-20 |
Firmenich Incorporated |
Compuestos útiles como moduladores de canal receptor 8 de potencial transitorio de melastatina (trpm8).
|
|
DK3388420T3
(da)
*
|
2015-12-07 |
2022-09-26 |
Hinova Pharmaceuticals Inc |
Quinolin-forbindelser, metode til fremstilling deraf og anvendelse deraf som urattransporter-hæmmende lægemiddel
|
|
RU2754507C2
(ru)
|
2016-06-24 |
2021-09-02 |
Инфинити Фармасьютикалз, Инк. |
Комбинированная терапия
|
|
EP3507288B1
(en)
|
2016-09-02 |
2020-08-26 |
Gilead Sciences, Inc. |
4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
|
|
CN109923106B
(zh)
|
2016-09-02 |
2022-09-13 |
吉利德科学公司 |
toll样受体调节剂化合物
|
|
US10722489B2
(en)
*
|
2016-10-31 |
2020-07-28 |
Peking University |
D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof
|
|
CN106565643A
(zh)
*
|
2016-10-31 |
2017-04-19 |
北京大学 |
D‑3‑磷酸甘油酸脱氢酶别构抑制剂及其应用
|
|
RS62959B1
(sr)
|
2017-01-11 |
2022-03-31 |
Alkermes Inc |
Biciklični inhibitori histon-deacetilaze
|
|
CN106822897B
(zh)
*
|
2017-02-17 |
2018-10-19 |
河北盛华尔生物医疗科技有限公司 |
靶向下调trpm7基因表达在提高肺鳞癌化疗敏感性方面的应用
|
|
BR112019020252A2
(pt)
*
|
2017-03-31 |
2020-04-22 |
Perenna Pharmaceuticals Inc |
compostos úteis como inibidores de alcat 1
|
|
WO2018232160A1
(en)
*
|
2017-06-15 |
2018-12-20 |
Belite Bio, Inc |
Methods of treating metabolic diseases with phenoxyethylamides
|
|
WO2018232150A1
(en)
|
2017-06-15 |
2018-12-20 |
Belite Bio, Inc |
Methods of treating rbp4 related diseases with triazolopyridines
|
|
EP3638238A4
(en)
|
2017-06-15 |
2021-03-10 |
Belite Bio, Inc |
METHOD OF TREATMENT OF METABOLIC DISEASES USING CONDENSED BICYCLIC PYRAZOLES
|
|
US11225475B2
(en)
|
2017-08-07 |
2022-01-18 |
Alkermes, Inc. |
Substituted pyridines as inhibitors of histone deacetylase
|
|
PY19106549A
(es)
*
|
2018-12-21 |
2021-07-13 |
Bayer Ag |
1,3,4-oxadiazoles y derivados de éstos como nuevos agentes fungicidas
|
|
TW202212339A
(zh)
|
2019-04-17 |
2022-04-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
TW202210480A
(zh)
|
2019-04-17 |
2022-03-16 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
TWI879779B
(zh)
|
2019-06-28 |
2025-04-11 |
美商基利科學股份有限公司 |
類鐸受體調節劑化合物的製備方法
|
|
KR20220061093A
(ko)
|
2019-07-08 |
2022-05-12 |
벨라이트 바이오 엘엘씨 |
Rbp4 억제제의 제제 및 사용 방법
|
|
CA3166630A1
(en)
|
2020-01-03 |
2021-07-08 |
Berg Llc |
Polycyclic amides as ube2k modulators for treating cancer
|
|
WO2021257857A1
(en)
|
2020-06-19 |
2021-12-23 |
Incyte Corporation |
Naphthyridinone compounds as jak2 v617f inhibitors
|
|
WO2021257863A1
(en)
|
2020-06-19 |
2021-12-23 |
Incyte Corporation |
Pyrrolotriazine compounds as jak2 v617f inhibitors
|
|
US11767323B2
(en)
|
2020-07-02 |
2023-09-26 |
Incyte Corporation |
Tricyclic pyridone compounds as JAK2 V617F inhibitors
|
|
SMT202500271T1
(it)
|
2020-07-02 |
2025-09-12 |
Incyte Corp |
Composti di urea triciclici come inibitori di v617f di jak2
|
|
US11661422B2
(en)
|
2020-08-27 |
2023-05-30 |
Incyte Corporation |
Tricyclic urea compounds as JAK2 V617F inhibitors
|
|
EP4255893A4
(en)
*
|
2020-12-04 |
2025-04-23 |
The Johns Hopkins University |
COMPOUNDS AND THEIR USE FOR THE TREATMENT OF NEUROPATHIC PAIN
|
|
WO2022140231A1
(en)
|
2020-12-21 |
2022-06-30 |
Incyte Corporation |
Deazaguaine compounds as jak2 v617f inhibitors
|
|
WO2022148781A1
(en)
|
2021-01-05 |
2022-07-14 |
Institut Curie |
Combination of mcoln activators and immune checkpoint inhibitors
|
|
AR125273A1
(es)
|
2021-02-25 |
2023-07-05 |
Incyte Corp |
Lactamas espirocíclicas como inhibidores de jak2 v617f
|
|
KR102905373B1
(ko)
*
|
2021-04-08 |
2025-12-29 |
주식회사 종근당 |
히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 싸이오카보닐 화합물 및 이를 포함하는 약제학적 조성물
|
|
CN114685371A
(zh)
*
|
2022-03-08 |
2022-07-01 |
四川大学 |
吡唑甲酰胺衍生物及其制备方法和用途
|
|
CN119173514A
(zh)
|
2022-03-17 |
2024-12-20 |
因赛特公司 |
作为jak2 v617f抑制剂的三环脲化合物
|
|
US20260085073A1
(en)
*
|
2022-09-12 |
2026-03-26 |
Hotspot Therapeutics, Inc. |
Pyrazolylcarboxamide compounds and their use in therapy
|